Evidence map›Paper›PMID 36672112›Full record

ReviewBrain sciences2023

Effects of COVID-19 on Synaptic and Neuronal Degeneration.

Mohammed S Alqahtani, Mohamed Abbas, Mohammad Y Alshahrani, Khulud Alabdullh, Amjad Alqarni, Fawaz F Alqahtani, Layal K Jambi, Adnan Alkhayat

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Brain sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 3 countries.

Mohammed S AlqahtaniRadiological Sciences Department, College of Applied Medical Sciences, King Khalid University, Abha 61421, Saudi Arabia.ORCID 0000-0001-7425-3578
Mohamed AbbasElectrical Engineering Department, College of Engineering, King Khalid University, Abha 61421, Saudi Arabia.ORCID 0000-0002-3141-2900
Mohammad Y AlshahraniDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha 61421, Saudi Arabia.ORCID 0000-0002-7096-0221
Khulud AlabdullhRadiology Department, King Abdullah Hospital Bisha, Bisha 61922, Saudi Arabia.
Amjad AlqarniRadiological Sciences Department, College of Applied Medical Sciences, King Khalid University, Abha 61421, Saudi Arabia.ORCID 0000-0002-5354-6678
Fawaz F AlqahtaniDepartment of Radiological Sciences, College of Applied Medical Sciences, Najran University, Najran 55461, Saudi Arabia.ORCID 0000-0003-1494-0303
Layal K JambiRadiological Sciences Department, College of Applied Medical Sciences, King Saud University, P.O. Box 10219, Riyadh 11433, Saudi Arabia.ORCID 0000-0002-2098-6925
Adnan AlkhayatDepartment of Hematopathology, King Fahad Central Hospital, Gizan 82666, Saudi Arabia.ORCID 0000-0002-1045-0721
King Khalid University · SAKing Fahad Central Hospital · SAKing Saud University · SANajran University · SAUniversity of Bisha · SAUniversity of Leicester · GB

Funding

King Khalid University R.G.P.1/349/43
6 · The paper itself

Abstract

Neurons are the basic building blocks of the human body's neurological system. Atrophy is defined by the disintegration of the connections between cells that enable them to communicate. Peripheral neuropathy and demyelinating disorders, as well as cerebrovascular illnesses and central nervous system (CNS) inflammatory diseases, have all been linked to brain damage, including Parkinson's disease (PD). It turns out that these diseases have a direct impact on brain atrophy. However, it may take some time after the onset of one of these diseases for this atrophy to be clearly diagnosed. With the emergence of the Coronavirus disease 2019 (COVID-19) pandemic, there were several clinical observations of COVID-19 patients. Among those observations is that the virus can cause any of the diseases that can lead to brain atrophy. Here we shed light on the research that tracked the relationship of these diseases to the COVID-19 virus. The importance of this review is that it is the first to link the relationship between the Coronavirus and diseases that cause brain atrophy. It also indicates the indirect role of the virus in dystrophy.

Indexed as

brain atrophycerebrovascular diseasesCNS inflammatory diseasesCOVID-19demyelinating disordersParkinson’s diseaseperipheral neuropathy

Identifiers

PMID36672112
PMCPMC9856402
OpenAlexW4315700856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.